上海细胞库
人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|
人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|
| 规格 | 价格 | 库存 |
|---|---|---|
| 50ug | ￥ 2480.00 | 10 |
| 产品编号 | bs-47091P |
| 英文名称 | Recombinant human FGFR1 Alpha (IIIc) protein, C-His-Avi (HEK293) |
| 中文名称 | 重组人FGFR1 alpha (IIIc)蛋白 |
| 别????名 | Fibroblast growth factor receptor 1; bFGF R; BFGFR; C FGR; CD 331; CD331; CD331 antigen; CEK; FGFBR; FGFR 1; FGF Receptor 1; FLG; FLG protein; FLJ14326; FLT 2; FLT2; Fms like tyrosine kinase 2; Fms related tyrosine kinase 2; Fms related tyrosine kinase 2 Pfeiffer syndrome; H2; H3; H4; H5; HBGFR; Heparin binding growth factor receptor; Hydroxyaryl protein kinase; KAL 2; KAL2; MFR; N SAM; N sam tyrosine kinase; Protein tyrosine kinase; Tyrosylprotein kinase; Basic fibroblast growth factor receptor 1; FGFR1_HUMAN; Recombinant human FGFR1 Alpha (IIIc) protein, C-His-Avi (HEK293)?? |
| 理论分子量 | 42kDa |
| 检测分子量 | Due to glycosylation, the protein migrates to 68-80 kDa based on Tris-Bis PAGE result. |
| 性????状 | Lyophilized powder |
| 浓????度 | ＞0.5 mg/ml |
| 物????种 | Human |
| 序????列 | 22-374/822 |
| 纯????度 | >95% as determined by Tris-Bis PAGE; >95% as determined by SEC-HPLC |
| 纯化方法 | AC |
| 内毒素 | <1.0 EU/μg as determined by LAL |
| 表达系统 | HEK293 cell |
| 活性 | Not tested |
| 标签 | C-His-Avi |
| 缓?冲?液 | Lyophilized from 0.22 um filtered solution in PBS (pH=7.4) with 5 mM DTT. Normally 5% trehalose is added as protectant before Lyophilization. |
| 保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 | |
| 产品图片 |  The purity of Human FGFR1 alpha (IIIc) is greater than 95% as determined by SEC-HPLC.  Human FGFR1 alpha (IIIc) on Tris-Bis PAGE under reduced conditions. The purity is greater than 95%. |
